Given the role of galectin-3 in driving both insulin resistance and inflammatory processes, targeting this pathway may offer new strategies for improving both metabolic and reproductive outcomes in women with PCOS (Kingwell, 2016; Yan et al., 2020). Here, LGALS3 is linked to polycystic ovary syndrome.